Why the study?
Predicting hemodynamic changes of stenotic MV lesions with MAC after TAVI may inform clinical decision-making, prompting evaluation of the link between CT-quantified MAC severity and post-TAVI hemodynamics.
Does mitral annular calcification severity affect changes in transmitral hemodynamics following TAVI in patients with severe aortic stenosis?
Does mitral annular calcification severity affect changes in transmitral hemodynamics following TAVI in patients with severe aortic stenosis?
Answers are grounded in this paper and cite their sources.
In patients undergoing TAVI for severe aortic stenosis, increasing severity of mitral annular calcification is associated with greater increases in post-procedural mean transmitral gradient, suggesting MAC severity should be considered if symptoms persist post-TAVI.
PURPOSES: Predicting hemodynamic changes of stenotic mitral valve (MV) lesions with mitral annular calcification (MAC) following transcatheter aortic valve implantation (TAVI) may inform clinical decision-making. This study aimed to investigate the association between the MAC severity quantified by computed tomography (CT) and changes in mean transmitral gradient (mTMG), mitral valve area (MVA) and stroke volume index (SVi) following TAVI. METHODS AND RESULTS: A total of 708 patients (median age 81, 52% male) with severe aortic stenosis (AS) underwent pre-procedural CT and pre- and post-TAVI transthoracic echocardiography. According to the classification of MAC severity determined by CT, 299 (42.2%) patients had no MAC, 229 (32.3%) mild MAC, 102 (14.4%) moderate MAC, and 78 (11.0%) severe MAC. After adjusting for age and sex, there was no significant change in mTMG following TAVI (Δ mTMG = 0.07 mmHg, 95% CI -0.10 to 0.23, P = 0.92) for patients with no MAC. In contrast, patients with mild MAC (Δ mTMG = 0.21 mmHg, 95% CI 0.01 to 0.40, P = 0.018), moderate MAC (Δ mTMG = 0.31 mmHg, 95% CI 0.02 to 0.60, P = 0.019) and severe MAC (Δ mTMG = 0.43 mmHg, 95% CI 0.10 to 0.76, P = 0.0012) had significant increases in mTMG following TAVI, with greater changes associated with increasing MAC severity. In contrast, there was no significant change in MVA or SVi following TAVI. CONCLUSION: In patients with severe AS undergoing TAVI, MAC severity was associated with greater increases in post-procedural mTMG whereas MVA or SVi remained unchanged. MAC severity should be considered for potential subsequent MV interventions if TAVI does not improve symptoms.
No takes yet. Share an insight, caveat, or question.
Hirasawa et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: